The impact of COVID‐19 on the provision of cardiac surgical services

Shafì, Ahmed Mohamed Abdel; Hewage, Savini; Harky, Amer

doi:10.1111/jocs.14631

Cited by 46 publications

(46 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…As society and healthcare seek to find a “new normal,” greater investments will need to be made in technological gaps around the UK so that the use of TM can become more common. The authors believe that more attention is needed to see how TM can be made more accessible to those best placed to benefit from it 68‐81 …”

Section: Conclusion and Future Researchmentioning

confidence: 99%

Telemedicine in cardiovascular surgery during COVID‐19 pandemic: A systematic review and our experience

et al. 2020

Self Cite

View full text Add to dashboard Cite

Objective The SAR‐COV‐2 pandemic has had an unprecedented effect on the UK's healthcare systems. To reduce spread of the virus, elective treatments and surgeries have been postponed or canceled. There has been a rise in the use of telemedicine (TM) as an alternative way to carry outpatient consultations. This systematic review aims to evaluate the extent to which TM may be able to support cardiac and vascular surgery patients in the COVID‐19 era. Methods We looked into how TM can support the management of patients via triaging, preoperative, and postoperative care. Evaluations targeted the clinical effectiveness of common TM methods and the feasibility of applying those methods in the UK during this pandemic. Results Several studies have published their evidence on the benefit of TM and its benefit during COVID‐19, the data related to cardiovascular surgery and how this will impact future practice of this speciality is emerging and yet larger studies with appropriate timing of outcomes to be published. Conclusion Overall, the use of virtual consultations and remote monitoring is feasible and best placed to support these patients via triaging and postoperative monitoring. However, TM can be limited by the need of sophisticated technological requirement and patients’ educational and know‐how computer literacy level.

show abstract

Section: Conclusion and Future Researchmentioning

confidence: 99%

Telemedicine in cardiovascular surgery during COVID‐19 pandemic: A systematic review and our experience

et al. 2020

Self Cite

View full text Add to dashboard Cite

show abstract

“…Significant concerns relating to COVID‐19 and the cardiovascular system have been highlighted, with COVID‐19 inducing multiple cytokines and chemokines resulting in vascular inflammation, plaque instability, and myocardial inflammation 1 . Additionally, pre‐existing cardiovascular disease (CVD) predisposes to COVID‐19 infection with elevated risk of adverse outcomes 2,3 . These concerns are compounded by results from previous epidemiologic and clinical studies, demonstrating that patients with pre‐existing coronary artery disease and/or risk factors for atherosclerotic disease are at an increased risk of developing acute coronary syndromes (ACS) during acute infection 4‐6 …”

Section: Introductionmentioning

confidence: 99%

Cardiac manifestations in COVID‐19 patients—A systematic review

et al. 2020

Self Cite

View full text Add to dashboard Cite

Objectives The coronavirus disease‐2019 (COVID‐19) pandemic has resulted in the worst global pandemic of our generation, affecting 215 countries with nearly 5.5 million cases. The association between COVID‐19 and the cardiovascular system has been well described. We sought to systematically review the current published literature on the different cardiac manifestations and the use of cardiac‐specific biomarkers in terms of their prognostic value in determining clinical outcomes and correlation to disease severity. Methods A systematic literature review across PubMed, Cochrane database, Embase, Google Scholar, and Ovid was performed according to PRISMA guidelines to identify relevant articles that discussed risk factors for cardiovascular manifestations, cardiac manifestations in COVID‐19 patients, and cardiac‐specific biomarkers with their clinical implications on COVID‐19. Results Sixty‐one relevant articles were identified which described risk factors for cardiovascular manifestations, cardiac manifestations (including heart failure, cardiogenic shock, arrhythmia, and myocarditis among others) and cardiac‐specific biomarkers (including CK‐MB, CK, myoglobin, troponin, and NT‐proBNP). Cardiovascular risk factors can play a crucial role in identifying patients vulnerable to developing cardiovascular manifestations of COVID‐19 and thus help to save lives. A wide array of cardiac manifestations is associated with the interaction between COVID‐19 and the cardiovascular system. Cardiac‐specific biomarkers provide a useful prognostic tool in helping identify patients with the severe disease early and allowing for escalation of treatment in a timely fashion. Conclusion COVID‐19 is an evolving pandemic with predominate respiratory manifestations, however, due to the interaction with the cardiovascular system; cardiac manifestations/complications feature heavily in this disease, with cardiac biomarkers providing important prognostic information.

show abstract

“…In particular, many primary care services have switched to virtual delivery, although there is insufficient evidence on the impact of such services on clinical outcomes and quality of healthcare 35 . To promote the expansion of telehealth in a post‐COVID era, collaborative research into the effectiveness of digital healthcare delivery is necessary 36‐40 . Professional and patient input, paired with government‐supported health technology expansions, is needed 34 to ensure that such developments do not exacerbate social inequalities and data security issues, but rather, that they improve digital literacy and remove barriers to healthcare.…”

Section: Persistency Of Digital Health Service Beyond Covid‐19mentioning

confidence: 99%